Table 1 Comparison between HPV and HPV/HIV co-infection with the different markers analyzed
NIC I | NICII/III | |||||
|---|---|---|---|---|---|---|
Marker | HPV/HIV- | HPV/HIV+ | P-value* | HPV/HIV- | HPV/HIV+ | P-value* |
VEGF-epit | ||||||
Mean (SD) | 74.9 (64.3) | 161 (63.0) | 0.001 | 89.6 (52.7) | 169.5 (56.6) | < 0.001 |
Median (IQR) | 70 (12 – 102) | 161 (104 – 220) | 82 (47 – 127) | 162 (125–220) | ||
(n) | (32) | (12) | (41) | (22) | ||
P27 epit | ||||||
Mean (SD) | 3.35 (20.5) | 24.5 (34.4) | < 0.001 | 4.85 (15.2) | 10.21 (12.0) | 0.001 |
Median (IQR) | 0 (0 – 0) | 10 (5 – 33) | 0 (0 – 3) | 8 (0–16) | ||
(n) | (31) | (13) | (32) | (22) | ||
Rb epit | ||||||
Mean (SD) | 11.5 (17.8) | 33.6 (52.6) | 0.141 | 3.41 (11.7) | 11.5 (25.5) | 0.110 |
Median (IQR) | 0 (0 – 24) | 19 (0 43) | 0 (0 – 0) | 0 (0–6) | ||
(n) | (29) | (13) | (41) | (21) | ||
Elf-1 epit | ||||||
Mean (SD) | 48.6 (60.4) | 93.1 (77.8) | 0.191 | 133.5 (96.4) | 98.5 (81.4) | 0.509 |
Median (IQR) | 20 (2 – 75) | 69 (35–177) | 99 (50 – 216) | 69 (43–161) | ||
(n) | (27) | (14) | (35) | (21) | ||